Ann: CBCF funding to support deoxymab brain cancer development, page-31

Hi Mal,
yes pretty frustrating that the SP is where it is and sentiment shifted for the time being….
you and many more are here because you believe in what PAB have got and what they intend to do with it….
When the broader market gains sentiment again with PAB we will get up there quickly.
As I have said previously it is only time that is our enemy at the moment, because if you hold and haven’t got the time then the pressures of having to sell and giving these up cheaply becomes more realistic….

I try to think of there being no more delays and we would of been in the clinic NOW, I try to guess what the SP would be but I can’t actually put a figure on it as I cannot monetise the enormity of what we have and the things that can and very possibly be able too….

we all have 1 stock in our portfolio that is weighted heavy in the risk category but I don’t think we are holding much risk now at this stage….

10c is certainly a minimum of where we need to be before deal/Kev/licensing talks start and I think we could be there be years end before the Tox report becomes available with new sentiment following it strongly